← Back to all trials
Completed
NCT07571148
Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT Users
Conditions: Schizophrenia
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Enrollment: 6876
Sponsor: Bristol-Myers Squibb
Location: Veradigm Chicago Illinois
Summary
This study uses existing health records and insurance claims data to understand how adults in the United States are treated with KarXT, a medication for schizophrenia. It will describe who receives KarXT, how it is used in real-world practice, and how often healthcare services such as hospital visits are used. It will also explore information recorded by clinicians about schizophrenia symptoms
Eligibility Criteria
Inclusion Criteria:
* Participants in the Veradigm EHR/claims-linked database with evidence of treatment with KarXT on or after September 24, 2024
* Earliest KarXT treatment date = index date
* Aged 18 years or older on index date
Exclusion Criteria:
* Not applicable
Source: ClinicalTrials.gov (NCT07571148). StuddyBuddy aggregates publicly available trial information.
